Perceptive Credit Holdings Sells $2 Million in Trinity Biotech ADSs
TRIB has more than doubled off its 52-week low of $0.48 on light trading volume (0.1× avg).
Summary
Perceptive Credit Holdings II, L.P. reported selling approximately $2 million worth of Trinity Biotech ADSs between December 23, 2025, and January 22, 2026, representing a significant disposition by a major institutional investor.
Key Events · Ownership and Investor Activity · TRIB
-
Significant Share Disposition
Perceptive Credit Holdings II, L.P. sold 1,989,000 ADSs (equivalent to 39,780,000 Ordinary Shares) between December 23, 2025, and January 22, 2026.
-
Substantial Value Sold
The total estimated value of the shares sold is approximately $2 million, representing a material portion of the company's market capitalization.
-
Declining Sale Prices
The sales occurred at weighted average prices ranging from $1.64 down to $0.70-$0.73 per ADS, indicating sustained selling pressure during a period of stock price decline.
-
Follows Resale Registration
This disposition follows the company's recent F-1 and 424B3 filings in January 2026, which registered shares for resale by Perceptive Credit Holdings.
Analysis · TRIB · Life Sciences
This Schedule 13D/A filing reveals that Perceptive Credit Holdings II, L.P., a significant institutional investor, has disposed of a substantial amount of American Depositary Shares (ADSs) in Trinity Biotech. The sales, totaling approximately $2 million, occurred over a month-long period at declining prices, following the recent registration of shares for resale. This sustained selling activity by a major holder, representing a material portion of the company's market capitalization, indicates a significant reduction in their exposure and could exert downward pressure on the stock. Investors should note the continued disposition by this key investor.
At the time of this filing, TRIB was trading at $0.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.9M. The 52-week trading range was $0.48 to $3.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.